Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Supplee JG"'
Autor:
Supplee JG; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Affronti HC; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Duan R; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Brooks RC; The Wistar Institute, Philadelphia, Pennsylvania, USA., Stine ZE; The Wistar Institute, Philadelphia, Pennsylvania, USA., Nguyen PTT; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Pinheiro LV; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Noji MC; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Drummond JM; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Huang K; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Schultz K; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Dang CV; The Wistar Institute, Philadelphia, Pennsylvania, USA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Ludwig Institute for Cancer Research, New York, New York, USA., Marmorstein R; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: marmor@upenn.edu., Wellen KE; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: wellenk@upenn.edu.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2024 Jul; Vol. 300 (7), pp. 107418. Date of Electronic Publication: 2024 May 28.
Autor:
Ben-Ami R; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Wang QL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Zhang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Supplee JG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lehmann-Werman R; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Nowak J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Loftus M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Babic A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Irajizad E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davidi T; Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel., Zick A; Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel., Hubert A; Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel., Neiman D; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Piyanzin S; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Gal-Rosenberg O; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Horn A; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Shemer R; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Glaser B; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel., Boos N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Jajoo K; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lee L; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Clancy TE; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Chabot JA; Department of Surgery, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA., Kastrinos F; Division of Digestive and Liver Diseases, Columbia University Irving Medical Cancer and the Vagelos College of Physicians and Surgeons, New York, New York, USA., Kluger M; Department of Surgery, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Bardeesy N; Massachusetts General Hospital Cancer Center, Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA., Stanger B; Department of Medicine, Division of Gastroenterology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., O'Hara MH; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Till J; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Maitra A; Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA., Carpenter EL; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Bullock AJ; Division of Hematology and Oncology, Beth-Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA., Genkinger J; Department of epidemiology, Mailman school of public health, Columbia university, New York, New York, USA.; Herbert Irving Comprehensive Cancer Center, Columbia university Irving Medical Center, New York, New York, USA., Hanash SM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Dor Y; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel Brian_Wolpin@dfci.harvard.edu yuvald@ekmd.huji.ac.il., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA Brian_Wolpin@dfci.harvard.edu yuvald@ekmd.huji.ac.il.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Gut [Gut] 2024 Mar 07; Vol. 73 (4), pp. 639-648. Date of Electronic Publication: 2024 Mar 07.
Autor:
Cheng ML; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lau CJ; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA., Milan MSD; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Supplee JG; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA., Riess JW; University of California Davis Comprehensive Cancer Center, Sacramento, CA., Bradbury PA; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Department of Medicine, University of Toronto, Toronto, ON, Canada., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA., Oxnard GR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Paweletz CP; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2021 Feb 17; Vol. 5. Date of Electronic Publication: 2021 Feb 17 (Print Publication: 2021).
Autor:
Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. Electronic address: glenn_hanna@dfci.harvard.edu., Lau CJ; Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA., Mahmood U; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Supplee JG; Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA., Mogili AR; Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA., Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA., Paweletz CP; Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA.
Publikováno v:
Oral oncology [Oral Oncol] 2019 Aug; Vol. 95, pp. 120-126. Date of Electronic Publication: 2019 Jun 20.
Autor:
Supplee JG; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, 360 Longwood Avenue, Boston, MA, 02215, USA. Electronic address: julianna_supplee@dfci.harvard.edu., Milan MSD; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. Electronic address: MarinaS_Milan@dfci.harvard.edu., Lim LP; Resolution Bioscience, Inc., 550 Kirkland Way, Kirkland, WA, 98033, USA. Electronic address: lplim@resolutionbio.com., Potts KT; Resolution Bioscience, Inc., 550 Kirkland Way, Kirkland, WA, 98033, USA. Electronic address: kristy@resolutionbio.com., Sholl LM; Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. Electronic address: lmsholl@bwh.harvard.edu., Oxnard GR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. Electronic address: geoffrey_oxnard@dfci.harvard.edu., Paweletz CP; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, 360 Longwood Avenue, Boston, MA, 02215, USA. Electronic address: cloudp_paweletz@dfci.harvard.edu.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2019 Aug; Vol. 134, pp. 96-99. Date of Electronic Publication: 2019 Jun 05.
Autor:
Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. Electronic address: glenn_hanna@dfci.harvard.edu., Supplee JG; Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA., Kuang Y; Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA., Mahmood U; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Lau CJ; Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA., Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA., Paweletz CP; Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Sep 01; Vol. 29 (9), pp. 1980-1986.